Form 483

Forma Life Sciences, Inc Form 483, 2010-03-15

FDA issued a Form 483 to Forma Life Sciences, Inc on 2010-03-15 with 10 public-safe observations.

483· Form 483 issued10 observations

Forma Life Sciences, Inc · Irvine, United States · Issued March 15, 2010

Overview

  • 10 public-safe observations are available for this inspection.
  • 10 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

15 Mar 2010
21 CFR 211.22(c)

Approve or reject procedures or specs

Cited by Uttaniti Limchumroon, Virgilio F Pacio

15 Mar 2010
21 CFR 211.63

Equipment Design, Size and Location

Cited by Uttaniti Limchumroon, Virgilio F Pacio

15 Mar 2010
21 CFR 211.67(b)

Written procedures fail to include

Cited by Uttaniti Limchumroon, Virgilio F Pacio

15 Mar 2010
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Uttaniti Limchumroon, Virgilio F Pacio

15 Mar 2010
21 CFR 211.165(e)

Test methods

Cited by Uttaniti Limchumroon, Virgilio F Pacio

Inspected site

FLForma Life Sciences, IncIrvine, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 10 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere